If you have a gut feeling something is preventing you from losing as much weight as you would like to, you could be right. Researchers found that the gut microbiome — the bacteria that help digest food and absorb nutrients in the intestines — can influence attempts at weight loss. They identified genes within these bacteria that determine how quickly the bacteria grow, how well people can take advantage of nutrients in food, and whether starches and fiber, in particular, get broken down into sugars too quickly to aid weight loss.

Patients with type 2 diabetes who received empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, were almost 40% less likely to have a kidney stone than patients who received placebo during a median 1.5 years of treatment. These findings are from an analysis of pooled data from phase 1-4 clinical trials of empagliflozin for blood glucose control in 15,081 patients with type 2 diabetes.

Does antiviral drugs cut down the vertical transmission of HSV?

My sister frequently suffers from nasal bleeding and needs to be taken to local practitioner for treatment. What investigations could be done for treatment guidance?